Sentien Biotechnologies closes series A financing to fund development of SBI-101 April 6, 2017 No Comments
Omeros reports further data from phase II trial of OMS-721 in serious kidney disorders March 31, 2017 No Comments
KPR-2579, a novel TRPM8 antagonist for the potential treatment of bladder hypersensitivity March 28, 2017 No Comments
Sunshine Lake Pharma identifies urate transporter 1/xanthine oxidase inhibitors March 17, 2017 No Comments
RSS